2 completed. 2 Phase 4.
| Phase | Trials | Status |
|---|---|---|
| Phase 4 | 2 | Completed 2 |
Follow Mohammed Mahmood Mohammed: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Impact of Vascular Endothelial Growth Factor Gene Polymorphisms on Bevacizumab Efficacy in a Sample of Iraqi Patients With Metastatic Colorectal Cancer Bevacizumab - Colo-rectal Cancer | Phase 4 | Completed | Mohammed Mahmood Mohammed | 157 | 2022-09-01 | 2025-02-25 |
| Impact of Dapagliflozin as Add-on Therapy on Glycemic Status and Quality of Life in Type 2 Diabetic Patients Dapagliflozin - Diabetic Nephropathy Type 2 | Phase 4 | Completed | Mohammed Mahmood Mohammed | 40 | 2022-05-01 | 2024-03-22 |
Bevacizumab (1) · dapagliflozin (1)
Iraq (2)